Membrane-type matrix metalloproteinases: Key mediators of leukocyte function

Journal of Leukocyte Biology

Volumn 94, Issue 2, 2013, Pages 237-246

  Marco, Marta ^a   Fortin, Carl ^b   Fulop, Tamas ^b  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Extracellular matrix; Immune system cells; Inflammation; Migration; Proteases

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 17; RANTES; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

B LYMPHOCYTE; BASOPHIL; CELL MEMBRANE; CELL SUBPOPULATION; DENDRITIC CELL; EOSINOPHIL; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE FUNCTION; MACROPHAGE; MONOCYTE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EXTRACELLULAR MATRIX; IMMUNE SYSTEM CELLS; INFLAMMATION; MIGRATION; PROTEASES;

ANIMALS; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INFLAMMATION; ISLETS OF LANGERHANS; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE SUBSETS; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MICE; MULTIPLE SCLEROSIS; NEUTROPHILS; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84880967566     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0612267     Document Type: Review

References (98)

1. Gonzalez, S., Gonzalez-Rodriguez, A. P., Suarez-Alvarez, B., Lopez-Soto, A., Huergo-Zapico, L., Lopez-Larrea, C. (2011) Conceptual aspects of self and nonself discrimination. Self Nonself 2, 19-25.
2. Owen, C. A. (2008) Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization. Int. J. Biochem. Cell Biol. 40, 1246-1272.
3. Owen, C. A., Campbell, E. J. (1999) The cell biology of leukocyte-mediated proteolysis. J. Leukoc. Biol. 65, 137-150.
4. Opdenakker, G., Van den Steen, P. E., Dubois, B., Nelissen, I., Van Coil lie, E., Masure, S., Proost, P., Van Damme, J. (2001) Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 69, 851-859.
5. Van Den Steen, P. E., Wuyts, A., Husson, S. J., Proost, P., Van Damme, J., Opdenakker, G. (2003) Gelatinase B/MMP-9 and neutrophil collage-nase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/ CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem. 270, 3739-3749.
6. Lagente, V., Le Quement, C., Boichot, E. (2009) Macrophage met-alloelastase (MMP-12) as a target for inflammatory respiratory diseases. Expert Opin. Ther. Targets 13, 287-295.
7. Mizoguchi, H., Yamada, K., Nabeshima, T. (2011) Matrix metalloprotei-nases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy. Biochem. Res. Int. 2011, 681385.
8. Moore, C. S., Crocker, S. J. (2012) An alternate perspective on the roles of TIMPs and MMPs in pathology. Am. J. Pathol. 180, 12-16.
9. Van Wart, H. E., Birkedal-Hansen, H. (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87, 5578-5582.
10. Rodriguez, D., Morrison, C. J., Overall, C. M. (2010) Matrix metallopro-teinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim. Biophys. Acta 1803, 39-54.
11. Kessenbrock, K., Plaks, V., Werb, Z. (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67.
12. Gonzalo, P., Guadamillas, M. C., Hernandez Riquer, M. V., Pollan, A., Grande-Garcia, A., Bartolome, R. A., Vasanji, A., Ambrogio, C., Chiarle, R., Teixido, J., Risteli, J., Apte, S. S., del Pozo, M. A., Arroyo, A. G. (2010) MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. Dev. Cell 18, 77-89.
13. Nyalendo, C., Michaud, M., Beaulieu, E., Roghi, C., Murphy, G., Gin-gras, D., Beliveau, R. (2007) Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration. J. Biol. Chem. 282, 15690-15699.
14. Rozanov, D. V., Deryugina, E. I., Ratnikov, B. I., Monosov, E. Z., March-enko, G. N., Quigley, J. P., Strongin, A. Y. (2001) Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J. Biol. Chem. 276, 25705-25714.
15. Sun, Q., Weber, C. R., Sohail, A., Bernardo, M. M., Toth, M., Zhao, H., Turner, J. R., Fridman, R. (2007) MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties. J. Biol. Chem. 282, 21998-22010.
16. Fortin, C. F., Sohail, A., Sun, Q., McDonald, P. P., Fridman, R., Fulop, T. (2010) MT6-MMP is present in lipid rafts and faces inward in living human PMNs but translocates to the cell surface during neutrophil apo-ptosis. Int. Immunol. 22, 637-649.
17. Sohail, A., Marco, M., Zhao, H., Shi, Q., Merriman, S., Mobashery, S., Fridman, R. (2011) Characterization of the dimerization interface of membrane type 4 (MT4)-matrix metalloproteinase. J. Biol. Chem. 286, 33178-33189.
18. Wang, Y., Johnson, A. R., Ye, Q. Z., Dyer, R. D. (1999) Catalytic activities and substrate specificity of the human membrane type 4 matrix metallo-proteinase catalytic domain. J. Biol. Chem. 274, 33043-33049.
19. English, W. R., Puente, X. S., Freije, J. M., Knauper, V., Amour, A., Merryweather, A., Lopez-Otin, C., Murphy, G. (2000) Membrane type4 matrix metalloproteinase (MMP17) has tumor necrosis factor-a convertase activity but does not activate pro-MMP2. J. Biol. Chem. 275, 14046-14055.
20. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., Goldberg, G. I. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270, 5331-5338.
21. Zhao, H., Bernardo, M. M., Osenkowski, P., Sohail, A., Pei, D., Nagase, H., Kashiwagi, M., Soloway, P. D., DeClerck, Y. A, Fridman, R. (2004) Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 regulates pro-MMP-2 activation. J. Biol. Chem. 279, 8592-8601.
22. Osenkowski, P., Toth, M., Fridman, R. (2004) Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J. Cell. Physiol. 200, 2-10.
23. Cauwe, B., Van den Steen, P. E., Opdenakker, G. (2007) The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 42, 113-185.
24. Parks, W. C, Wilson, C. L., Lopez-Boado, Y S. (2004) Matrix metallo-proteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4, 617-629.
25. Barbolina, M. V., Stack, M. S. (2008) Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. Semin. Cell. Dev. Biol. 19, 24-33.
26. English, W. R, Velasco, G., Stracke, J. O., Knauper, V., Murphy, G (2001) Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25). FEBS Lett. 491, 137-142.
27. Tam, E. M., Morrison, C. J., Wu, Y I., Stack, M. S., Overall, C. M. (2004) Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl. Acad. Sci. USA 101, 6917-6922.
28. Starr, A. E., Bellac, C. L., Dufour, A, Goebeler, V., Overall, C. M. (2012) Biochemical characterization and N-terminomics analysis of leu-kolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemo-kine and vimentin cleavages enhance cell migration and macrophage phagocytic activities. J. Biol. Chem. 287, 13382-13395.
29. Wiesner, C, Faix, J., Himmel, M., Bentzien, F., Linder, S. (2010) KIF5B and KIF3A/KIF3B kinesins drive MT1-MMP surface exposure, CD44 shedding, and extracellular matrix degradation in primary macrophages. Blood 116, 1559-1569.
30. Nusblat, L. M., Dovas, A, Cox, D. (2011) The non-redundant role of N-WASP in podosome-mediated matrix degradation in macrophages. Eur. J. Cell Biol. 90, 205-212.
31. Castro-Castro, A, Janke, C, Montagnac, G., Paul-Gilloteaux, P., Chavrier, P. (2012) ATAT1/MEC-17 acetyltransferase and HDAC6 deacetylase control a balance of acetylation of a-tubulin and cortactin and regulate MT1-MMP trafficking and breast tumor cell invasion. Eur. J. Cell Biol. 91, 950-960.
32. Poincloux, R., Lizarraga, F., Chavrier, P. (2009) Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J. Cell Sci. 122, 3015-3024.
33. Adair-Kirk, T. L., Senior, R M. (2008) Fragments of extracellular matrix as mediators of inflammation. Int. J. Biochem. Cell Biol. 40, 1101-1110.
34. Korpos, E., Wu, C, Sorokin, L. (2009) Multiple roles of the extracellular matrix in inflammation. Curr. Pharm. Des. 15, 1349-1357.
35. Garton, K. J., Gough, P. J., Raines, E. W. (2006) Emerging roles for ect-odomain shedding in the regulation of inflammatory responses. J. Leu-koc. Biol. 79, 1105-1116.
36. Kajita, M., Itoh, Y, Chiba, T., Mori, H., Okada, A, Kinoh, H., Seiki, M. (2001) Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 153, 893-904.
37. Sithu, S. D., English, W. R, Olson, P., Krubasik, D., Baker, A. H., Murphy, G., D'Souza, S. E. (2007) Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration. J. Biol. Chem. 282, 25010-25019.
38. Endo, K, Takino, T., Miyamori, H., Kinsen, H., Yoshizaki, T., Furukawa, M., Sato, H. (2003) Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J. Biol. Chem. 278, 40764-40770.
39. Salmi, M., Jalkanen, S. (2005) Cell-surface enzymes in control of leukocyte trafficking. Nat. Rev. Immunol. 5, 760-771.
40. Savinov, A. Y, Strongin, A. Y (2009) Matrix metalloproteinases, T cell homing and /3-cell mass in type 1 diabetes. Vitam. Horm. 80, 541-562.
41. Su, G., Blaine, S. A, Qiao, D., Friedl, A. (2008) Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation. Cancer Res. 68, 9558-9565.
42. Belkin, A. M., Akimov, S. S., Zaritskaya, L. S., Ratnikov, B. I., Deryugina, E. I., Strongin, A. Y (2001) Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J. Biol. Chem. 276, 18415-18422.
43. Starr, A. E., Dufour, A, Maier, J., Overall, C. M. (2012) Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16. J. Biol. Chem. 287, 5848-5860.
44. Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., Opdenak-ker, G. (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-a and leaves RANTES and MCP-2 intact. Blood 96, 2673-2681.
45. Berahovich, R. D., Miao, Z., Wang, Y., Premack, B., Howard, M. C, Schall, T.J. (2005) Proteolytic activation of alternative CCR1 ligands in inflammation. J. Immunol. 174, 7341-7351.
46. Richter, R, Bistrian, R, Escher, S., Forssmann, W. G., Vakili, J., Hen-schler, R, Spodsberg, N., Frimpong-Boateng, A., Forssmann, U. (2005) Quantum proteolytic activation of chemokine CCL15 by neutrophil granulocytes modulates mononuclear cell adhesiveness. J. Immunol. 175, 1599-1608.
47. Karsdal, M. A, Larsen, L., Engsig, M. T., Lou, H., Ferreras, M., Lochter, A, Delaisse, J. M., Foged, N. T. (2002) Matrix metalloproteinase-depen-dent activation of latent transforming growth factor-/3 controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J. Biol. Chem. 277, 44061-44067.
48. McQuibban, G. A, Gong, J. H., Wong, J. P., Wallace, J. L., Clark-Lewis, I., Overall, C. M. (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100, 1160-1167.
49. McQuibban, G. A, Butler, G. S., Gong, J. H., Bendall, L., Power, C, Clark-Lewis, I., Overall, C. M. (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503-43508.
50. D'Ortho, M. P., Will, H., Atkinson, S., Butler, G., Messent, A, Gavrilovic, J., Smith, B., Timpl, R, Zardi, L., Murphy, G. (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250, 751-757.
51. Rikimaru, A, Komori, K, Sakamoto, T., Ichise, H., Yoshida, N., Yana, I., Seiki, M. (2007) Establishment of an MT4-MMP-deficient mouse strain representing an efficient tracking system for MT4-MMP/MMP-17 expression in vivo using /3-galactosidase. Genes Cells 12, 1091-1100.
52. Nie, J., Pei, D. (2004) Rapid inactivation of a-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6. Exp. Cell. Res. 296, 145-150.
53. Bar-Or, A, Nuttall, R K, Duddy, M., Alter, A, Kim, H. J., Ifergan, I., Pennington, C. J., Bourgoin, P., Edwards, D. R., Yong, V. W. (2003) Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 126, 2738-2749.
54. Gauthier, M. C, Racine, C, Ferland, C, Flamand, N., Chakir, J., Trem-blay, G. M., Laviolette, M. (2003) Expression of membrane type-4 matrix metalloproteinase (metalloproteinase-17) by human eosinophils. Int. J. Biochem. Cell Biol. 35, 1667-1673.
55. Huang, W. C, Sala-Newby, G. B., Susana, A, Johnson, J. L., Newby,C. (2012) Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-KB. PLoS One 7, e42507.
56. Hald, A, Rono, B., Lund, L. R, Egerod, K L. (2012) LPS counter regulates RNA expression of extracellular proteases and their inhibitors in murine macrophages. Mediators Inflamm. 2012, 157-894.
57. Reel, B., Sala-Newby, G. B., Huang, W. C, Newby, A. C. (2011) Diverse patterns of cyclooxygenase-independent metalloproteinase gene regulation in human monocytes. Br. J. Pharmacol. 163, 1679-1690.
58. Shankavaram, U. T., Lai, W. C, Netzel-Arnett, S., Mangan, P. R, Ar-dans, J. A, Caterina, N., Stetler-Stevenson, W. G., Birkedal-Hansen, H., Wahl, L. M. (2001) Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloprotei-nase-2 activation. J. Biol. Chem. 276, 19027-19032.
59. Zhang, J., Hampton, A. L., Nie, G., Salamonsen, L. A. (2000) Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium. Biol. Reprod. 62, 85-94.
60. Chun, T. H., Sabeh, F., Ota, I., Murphy, H., McDonagh, K T., Holm-beck, K, Birkedal-Hansen, H., Allen, E. D., Weiss, S.J. (2004) MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J. Cell Biol. 167, 757-767.
61. Sabeh, F., Ota, I., Holmbeck, K, Birkedal-Hansen, H., Soloway, P., Bal-bin, M., Lopez-Otin, C, Shapiro, S., Inada, M., Krane, S., Allen, E., Chung, D., Weiss, S.J. (2004) Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol. 167, 769-781.
62. Matias-Roman, S., Galvez, B. G., Genis, L., Yanez-Mo, M., de la Rosa, G., Sanchez-Mateos, P., Sanchez-Madrid, F., Arroyo, A. G. (2005) Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood 105, 3956-3964.
63. Hara, T., Mimura, K, Seiki, M., Sakamoto, T. (2011) Genetic dissection of proteolytic and non-proteolytic contributions of MT1-MMP to macrophage invasion. Biochem. Biophys. Res. Commun. 413, 277-281.
64. Sakamoto, T., Seiki, M. (2009) Cytoplasmic tail of MT1-MMP regulates macrophage motility independently from its protease activity. Genes Cells 14, 617-626.
65. Shimizu-Hirota, R, Xiong, W., Baxter, B. T., Kunkel, S. L., Maillard, I., Chen, X. W., Sabeh, F., Liu, R, Li, X. Y, Weiss, S. J. (2012) MT1-MMP regulates the PI3K8·Mi-2/NuRD-dependent control of macrophage immune function. Genes Dev. 26, 395-413.
66. Xiong, W., Knispel, R, MacTaggart, J., Greiner, T. C, Weiss, S. J., Baxter, B. T. (2009) Membrane-type 1 matrix metalloproteinase regulates macrophage-dependent elastolytic activity and aneurysm formation in vivo. J. Biol. Chem. 284, 1765-1771.
67. Verollet, C, Charriere, G. M., Labrousse, A, Cougoule, C, Le Cabec, V, Maridonneau-Parini, I. (2011) Extracellular proteolysis in macrophage migration: losing grip for a breakthrough. Eur. J. Immunol. 41, 2805-2813.
68. Lehti, K, Allen, E., Birkedal-Hansen, H., Holmbeck, K, Miyake, Y, Chun, T. H., Weiss, S. J. (2005) An MT1-MMP-PDGF receptor-/3 axis regulates mural cell investment of the microvasculature. Genes Dev. 19, 979-991.
69. D'Alessio, S., Ferrari, G., Cinnante, K, Scheerer, W., Galloway, A. C, Roses, D. F., Rozanov, D. V., Remacle, A. G., Oh, E. S., Shiryaev, S. A, Strongin, A. Y, Pintucci, G., Mignatti, P. (2008) Tissue inhibitor of met-alloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. J. Biol. Chem. 283, 87-99.
70. Noirey, N., Staquet, M. J., Gariazzo, M. J., Serres, M., Andre, C, Schmitt, D., Vincent, C. (2002) Relationship between expression of matrix metalloproteinases and migration of epidermal and in vitro generated Lang-erhans cells. Eur. J. Cell Biol. 81, 383-389.
71. Yang, M. X., Qu, X., Kong, B. H., Lam, Q. L., Shao, Q. Q, Deng, B. P., Ko, K H., Lu, L. (2006) Membrane type 1-matrix metalloproteinase is involved in the migration of human monocyte-derived dendritic cells. Immunol. Cell Biol. 84, 557-562.
72. Alvarez, D., Vollmann, E. H., von Andrian, U. H. (2008) Mechanisms and consequences of dendritic cell migration. Immunity 29, 325-342.
73. Kim, M. H., Albertsson, P., Xue, Y, Kitson, R P., Nannmark, U., Gold-farb, R H. (2000) Expression of matrix metalloproteinases and their inhibitors by rat NK cells: inhibition of their expression by genistein. In Vivo 14, 557-564.
74. Kim, M. H., Kitson, R P., Albertsson, P., Nannmark, U., Basse, P. H., Kuppen, P. J., Hokland, M. E., Goldfarb, R H. (2000) Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. J. Immunol. 164, 5883-5889.
75. Edsparr, K, Johansson, B. R, Goldfarb, R H., Basse, P. H., Nannmark, U., Speetjens, F. M., Kuppen, P. J., Lennernas, B., Albertsson, P. (2009) Human NK cell lines migrate differentially in vitro related to matrix interaction and MMP expression. Immunol. Cell Biol. 87, 489-495.
76. Edsparr, K, Speetjens, F. M., Mulder-Stapel, A, Goldfarb, R H., Basse, P. H., Lennernas, B., Kuppen, P. J., Albertsson, P. (2010) Effects of IL-2 on MMP expression in freshly isolated human NK cells and the IL-2-independent NK cell line YT. J. Immunother. 33, 475-481.
77. Ishida, Y, Migita, K, Izumi, Y, Nakao, K, Ida, H., Kawakami, A, Abiru, S., Ishibashi, H., Eguchi, K, Ishii, N. (2004) The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells. FEBS Lett. 569, 156-160.
78. Pei, D. (1999) Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell. Res. 9, 291-303.
79. Nebl, T., Pestonjamasp, K N., Leszyk, J. D., Crowley, J. L., Oh, S. W., Luna, E. J. (2002) Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. J. Biol. Chem. 277, 43399-43409.
80. Kang, T., Yi, J., Guo, A, Wang, X., Overall, C. M., Jiang, W., Elde, R, Borregaard, N., Pei, D. (2001) Subcellular distribution and cytokine-and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils. J. Biol. Chem. 276, 21960-21968.
81. Nie, J., Pei, D. (2003) Direct activation of pro-matrix metalloprotei-nase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond. Cancer Res. 63, 6758-6762.
82. Velasco, G., Cal, S., Merlos-Suarez, A, Ferrando, A. A, Alvarez, S., Na-kano, A, Arribas, J., Lopez-Otin, C. (2000) Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res. 60, 877-882.
83. Matsuda, A, Itoh, Y, Koshikawa, N., Akizawa, T., Yana, I., Seiki, M. (2003) Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils. J. Biol. Chem. 278, 36350-36357.
84. Moisan, E., Girard, D. (2006) Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J. Leukoc. Biol. 79, 489-498.
85. Kimata, M., Ishizaki, M., Tanaka, H., Nagai, H., Inagaki, N. (2006) Production of matrix metalloproteinases in human cultured mast cells: involvement of protein kinase C-mitogen activated protein kinase kinase-extracellular signal-regulated kinase pathway. Allergol. Int. 55, 67-76.
86. Rajavashisth, T. B., Xu, X. P., Jovinge, S., Meisel, S., Xu, X. O., Chai, N. N., Fishbein, M. C., Kaul, S., Cercek, B., Sharifi, B., Shah, P. K. (1999) Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 99, 3103-3109.
87. Stawowy, P., Meyborg, H., Stibenz, D., Borges Pereira Stawowy, N., Roser, M., Thanabalasingam, U., Veinot, J. P., Chretien, M., Seidah, N. G., Fleck, E., Graf, K. (2005) Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis. Circulation 111, 2820-2827.
88. Uzui, H., Harpf, A., Liu, M., Doherty, T. M., Shukla, A., Chai, N. N., Tripathi, P. V., Jovinge, S., Wilkin, D. J., Asotra, K., Shah, P. K., Ra-javashisth, T. B. (2002) Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 106, 3024-3030.
89. Yu, Y., Koike, T., Kitajima, S., Liu, E., Morimoto, M., Shiomi, M., Hat-akeyama, K., Asada, Y., Wang, K. Y., Sasaguri, Y., Watanabe, T., Fan, J. (2008) Temporal and quantitative analysis of expression of metallopro-teinases (MMPs) and their endogenous inhibitors in atherosclerotic lesions. Histol. Histopathol. 23, 1503-1516.
90. Savinov, A. Y., Strongin, A. Y. (2007) Defining the roles of T cell membrane proteinase and CD44 in type 1 diabetes. IUBMB Life 59, 6-13.
91. Pap, T., Shigeyama, Y., Kuchen, S., Fernihough, J. K., Simmen, B., Gay, R. E., Billingham, M., Gay, S. (2000) Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis. Rheum. 43, 1226-1232.
92. Dreier, R., Grassel, S., Fuchs, S., Schaumburger, J., Bruckner, P. (2004) Pro-MMP-9 is a specific macrophage product and is activated by osteoar-thritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. Exp. Cell. Res. 297, 303-312.
93. Martel-Pelletier, J., Welsch, D. J., Pelletier, J. P. (2001) Metalloproteases and inhibitors in arthritic diseases. Best Pract. Res. Clin. Rheumatol. 15, 805-829.
94. Toft-Hansen, H., Babcock, A. A., Millward, J. M., Owens, T. (2007) Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system. J. Neuroinflammation 4, 24.
95. Toft-Hansen, H., Nuttall, R. K, Edwards, D. R., Owens, T. (2004) Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J. Immunol. 173, 5209-5218.
96. Shiryaev, S. A, Remacle, A. G., Savinov, A. Y., Chernov, A. V., Cieplak, P., Radichev, I. A, Williams, R, Shiryaeva, T. N., Gawlik, K, Postnova, T. I., Ratnikov, B. I., Eroshkin, A. M., Motamedchaboki, K, Smith, J. W., Strongin, A. Y. (2009) Inflammatory proprotein convertase-matrix metal-loproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis. J. Biol. Chem. 284, 30615-30626.
97. Graesser, D., Mahooti, S., Haas, T., Davis, S., Clark, R B., Madri, J. A (1998) The interrelationship of a4 integrin and matrix metalloprotei-nase-2 in the pathogenesis of experimental autoimmune encephalomyelitis. Lab. Invest. 78, 1445-1458.
98. Hayashi, K, Osada, S., Shofuda, K, Horikoshi, S., Shirato, I., Tomino, Y (1998) Enhanced expression of membrane type-1 matrix metalloprotei-nase in mesangial proliferative glomerulonephritis. J. Am. Soc. Nephrol. 9, 2262-2271.